Metabolomic Dx Raises $848K to Develop Pre-eclampsia Test | GenomeWeb

NEW YORK (GenomeWeb) – Metabolomic Diagnostics said this week it raised €750,000 ($848,000) in a second funding round that brings the total amount of investments in the firm to €1.5 million. 

Based in County Cork, Ireland, Metabolomic Dx is developing a predictive diagnostic test for the early detection of pre-eclampsia during pregnancy. The firm named SOSVentures Ireland Fund and AIB Seed Capital Fund as investors. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.